Azopt

Azopt

brinzolamide

Manufacturer:

Novartis

Distributor:

DKSH
Concise Prescribing Info
Contents
Brinzolamide
Indications/Uses
Elevated IOP in ocular HTN or open-angle glaucoma.
Dosage/Direction for Use
1 drop into conjunctival sac of affected eye bd. Max: Not to exceed 1 drop tds.
Contraindications
Hypersensitivity to brinzolamide or sulphonamides. Hyperchloraemic acidosis. Severe renal impairment.
Special Precautions
Discontinue use if serious reactions or hypersensitivity occur. Risk of metabolic acidosis. Patients w/ compromised corneas eg, w/ DM or corneal dystrophies; low endothelial cell count. May cause eye irritation due to benzalkonium Cl. Remove contact lens prior to application & wait at least 15 min before reinsertion. Not recommended to use w/ another carbonic anhydrase inhibitors. May affect ability to drive & use machines. Not recommended in hepatic & severe renal impairment. Not recommended during pregnancy. Lactation. Not recommended in childn <18 yr.
Adverse Reactions
Blurred vision, eye irritation & pain, ocular discomfort & hyperaemia; dysgeusia.
Drug Interactions
Potential additive effect w/ oral carbonic anhydrase inhibitor.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EC04 - brinzolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.
Presentation/Packing
Form
Azopt ophth susp 10 mg/mL
Packing/Price
5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in